Experimental Study on the Mechanical Properties of Amorphous Alloy Fiber‐Reinforced Concrete

Abstract

With great mechanical properties and corrosion resistance, amorphous alloy fiber (AAF) is a highly anticipated material in the fiber-reinforced concrete (FRC) field. In this study, the mechanical properties of AAFRC such as compressive strength, tensile strength, and flexural strength were examined. The comparison and analysis between AAFRC and steel fiber-reinforced concrete (SFRC) were also carried out. The results show that adding fibers significantly improves the concrete strength and toughness index. Compared with plain concrete, the compressive strength, splitting tensile strength, and flexural strength of AAFRC increase by 8.21–16.72%, 10.4–32.8%, and 18.12–45.21%, respectively. Meanwhile, the addition of AAF with a greater tensile strength and larger unit volume quantity improves the splitting tensile strength and flexural strength of concrete more noticeably than that of SF. Adding AAF improves the ductility of concrete more significantly in comparison to the SF. AAFRC shows great interfacial bonding performance as well. A prediction equation for the strength of AAFRC was proposed, which verified good accuracy calibrated based on the test results.

Experimental Study on Dynamic and Static Tensile Properties of a New Environmental Protection Material

“…The results show more fiber content raised the static tensile strength of concrete evidently, while the extent of increase tends to decrease [3]. Wu and Feng completed impact compression tests on four concrete specimens with different carbon fiber content under different strain rates and analyzed their stress-strain curves change rules [4]. Wang et al studied the torsional performance of carbon fiber-reinforced polymerround steel tube concrete.…”

Amorphous gray iron for concrete reinforcement

“…A genre of corrosion-resistant amorphous metallic fibers (AMF) has been shown to have the ability to significantly enhance the flexural strength of concrete, even at relatively low dosages [3,4].…”